http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0340780-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-18
filingDate 1989-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1991-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0340780-A3
titleOfInvention Azidochlorination and diazidization of glycals
abstract The invention describes a one-pot single step nprocedure for the azidochlorination or diazidization of nglycals, including glycal elements of carbohydrates. nCompounds such as 3,4,6-tri-O-benzyl-2-azido-2-deoxy-­nalpha-D-galactopyranosyl chloride, and 3,4,6-tri-O-­nbenzyl-2-azido-2-deoxy-alpha-,beta-D-galactopyranose nare prepared from tri-O-benzyl galactal as well as n3,4,6-tri-O-acetyl-2-azido-2-deoxy-D-alpha-­ngalactopyranosyl chloride and 3,6,-di-O-acetyl-4-O-­n[2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl]-2-­nazido-2-deoxy-alpha-D-glycopyranosyl chloride from ntheir respective O-acetylated glycal derivatives by the naddition of azido chloride which is chemically ngenerated in situ. A method using 3,4,6-tri-O-acetyl-­n2-azido-2-deoxy-alpha-D-galacto-pyranosyl chloride for nthe synthesis of antigenic determinants such as the nterminal asialo GM₁(beta-D-Gal (1->3)-beta-D-GalNAc-OR) nhas been demonstrated. The conversion of the subject nsynthon into 3,4,6-tri-O-acetyl-2-azido-2-deoxy-alpha-­nD-galactopyranosyl bromide and 1,3,4,6-tetra-O-acetyl-­n2-azido-2-deoxy-alpha-D-galactopyranose is also ndescribed. A further method for the synthetic ngeneration of the Tn antigen (alpha-D-GalNAc-O-L-­nserine) is also described.
priorityDate 1988-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4362720-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1011690-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2630596-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426198868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232801489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231582665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226748726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229345368
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6450363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2734735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12821201
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235178941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235178678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426110306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421723457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235178946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232025652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421723518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421723460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229305154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419510484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18639759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231394832
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12795697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10872911

Total number of triples: 46.